Related Experiment Video
Updated: May 21, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Non-steroidal anti-inflammatory drug-induced colopathy
Mads Klein1, Dorte Linnemann, Jacob Rosenberg
1Department of Surgical Gastroenterology, Herlev Hospital, Herlev, Denmark.
Abstract:
Non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy, comprising inflammation, ulceration, occult bleeding and subsequent healing with stricture formation in the small bowel, has become an established clinical entity. Recently, reports of similar pathological changes in the colon have led to increasing awareness of, what is termed, NSAID-induced colopathy. The authors here present a case of NSAID-induced colopathy with diaphragm formation in the colon. Diaphragms are thickened mucosal folds which can completely obliterate the bowel lumen. NSAID-induced colopathy can present with iron-deficiency anaemia, abdominal pain, weight loss, blood-positive stools or altered bowel habits, thus mimicking colon cancer. Acute presentation with bowel obstruction and/or perforation can also occur. Management involves withdrawal of the offending NSAID, excluding differential diagnoses such as inflammatory bowel disease and malignancy, and sometimes surgery with resection. With the increased use of coated and slow-release formulations of NSAIDs, increased awareness with regard to this clinical entity is relevant.
More Related Videos
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

